IL6 and breast carcinoma: Overall, these data expand our previous findings of an Sdc-1-dependent modulation of a CSC phenotype in breast cancer cells via the IL6/STAT3-, Wnt- and Notch-pathways and suggest that Sdc-1 knockdown may induce differentiation of the CSC population, thus attenuating malignant properties.